Understanding the sources of errors in ex vivo Hsp90 molecular imaging for rapid-on-site breast cancer diagnosis

Roujia Wang, Daniel A. Alvarez, Brian T. Crouch, Aditi Pilani, Christopher Lam, Caigang Zhu, Philip Hughes, David Katz, Timothy Haystead, Nirmala Ramanujam

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Overexpression of heat shock protein 90 (Hsp90) on the surface of breast cancer cells makes it an attractive molecular biomarker for breast cancer diagnosis. Before a ubiquitous diagnostic method can be established, an understanding of the systematic errors in Hsp90-based imaging is essential. In this study, we investigated three factors that may influence the sensitivity of ex vivo Hsp90 molecular imaging: time-dependent tissue viability, nonspecific diffusion of an Hsp90 specific probe (HS-27), and contact-based imaging. These three factors will be important considerations when designing any diagnostic imaging strategy based on fluorescence imaging of a molecular target on tissue samples.

Original languageEnglish
Pages (from-to)2299-2311
Number of pages13
JournalBiomedical Optics Express
Volume12
Issue number4
DOIs
StatePublished - Apr 2021

Bibliographical note

Publisher Copyright:
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.

Funding

National Institute of Biomedical Imaging and Bioengineering (5R01EB028148-02, 5R21EB025008-02). Acknowledgements. This work was supported by generous funding from NIH (5R21EB025008-02, 5R01EB028148-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

FundersFunder number
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering5R21EB025008-02, 5R01EB028148-02

    ASJC Scopus subject areas

    • Biotechnology
    • Atomic and Molecular Physics, and Optics

    Fingerprint

    Dive into the research topics of 'Understanding the sources of errors in ex vivo Hsp90 molecular imaging for rapid-on-site breast cancer diagnosis'. Together they form a unique fingerprint.

    Cite this